Interpace Biosciences
Pre-clinicalInterpace Diagnostics Group provides clinically useful molecular and related first line diagnostic tests for evaluating risk of cancer.
Founded
2003
Focus
Diagnostics
About
Interpace Diagnostics Group provides clinically useful molecular and related first line diagnostic tests for evaluating risk of cancer.
Funding History
3Total raised: $30M
Debt$5MUndisclosedNov 15, 2018
Series B$15MUndisclosedMar 15, 2016
Series A$10MUndisclosedJun 15, 2014
Company Info
TypePrivate
Founded2003
LocationParsippany, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile